Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 2.38MCore Assets
VS
Market
Sector
Industry
History
$ 9.52Close
$ 5.09 - $ 94.02 52-Week Range
Ticker Information
Ticker
CNSPCompany Name
CNS PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCNS PHARMACEUTICALS INC - Core Assets Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CNSP - Core Assets Historical data
| Date | Total Assets | Cash and Equivalents | Core Assets | Goodwill and Intangibles |
|---|---|---|---|---|
| 6/30/2025 | $ 14.51M | $ 12.13M | $ 2.38M | $ 0 |
| 3/31/2025 | $ 13.75M | $ 13.05M | $ 701.72K | $ 0 |
| 12/31/2024 | $ 8.7M | $ 6.46M | $ 2.24M | $ 0 |
| 9/30/2024 | $ 7.41M | $ 6.97M | $ 436.15K | $ 0 |
| 6/30/2024 | $ 2.47M | $ 1.49M | $ 977.71K | $ 0 |
| 3/31/2024 | $ 1.66M | $ 815.23K | $ 845.65K | $ 0 |
| 12/31/2023 | $ 1.7M | $ 548.72K | $ 1.15M | $ 0 |
| 9/30/2023 | $ 2.33M | $ 909.55K | $ 1.42M | $ 0 |
| 6/30/2023 | $ 6.45M | $ 4.28M | $ 2.17M | $ 0 |
| 3/31/2023 | $ 7.41M | $ 5.11M | $ 2.3M | $ 0 |
Key Performance Insights, Last 5 Years
- CNS PHARMACEUTICALS INC's latest trailing twelve months (TTM) Core Assets stands at $ 1.68M.
- Over the past 5 years, CNS PHARMACEUTICALS INC's average Core Assets has been $ 2.35M.
- The median Core Assets for CNS PHARMACEUTICALS INC during this period was $ 2.21M
- CNS PHARMACEUTICALS INC reached its highest Core Assets over the past 5 years at $ 7.35M.
- The lowest Core Assets recorded by CNS PHARMACEUTICALS INC in the same timeframe $ 436.15K
Similar metrics to Intangibles:
- Tangible Assets - [Calculation] A tangible asset is an asset that has physical substance. Typical examples may include [Inventory], equipment or machinery an property. It is calculated by subtracting intangibles & goodwill [Intangibles] from total [Assets].
- Goodwill & Intangibles to Assets Ratio - [Calculation] The [Intangibles] to [Assets] ratio is used as a company valuation factor by investors. Goodwill & Intangibles represent hard-to-value assets like a company’s brand name, solid customer relations, intellectual property, etc.
- Cash to Assets Ratio - [Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
- Goodwill and Intangibles - [Balance Sheet] Goodwill and Intangible Assets are a component of [Assets] representing nonphysical assets like goodwill, patents, trademarks, and copyrights; net of accumulated amortization and impairment charges.
- Current Assets - [Balance Sheet] The current (short-term) portion of [Assets] that are usually convertible to cash within a year; reported if the company operates a classified balance sheet that segments current and non-current assets.
Definition of Core Assets
[Calculation] The core assets of a company represents the total [Assets] minus cash & equivalents [CashnEq] minus intangibles & goodwill [Intangibles].Assets - Intangibles - CashnEq
(=) Core Assets Core Assets for CNS PHARMACEUTICALS INC is calculated as follows: Assets [ $ 2.99M ] - Intangibles [ $ 0 ] - CashnEq [ $ 1.31M ]
(=) Core Assets [ $ 1.68M ] CNSP - Core Assets, Last 5 years
$ 436.15K
Minimum
Sep 30, 2024
$ 7.35M
Maximum
Jun 30, 2021
$ 2.35M
Average
$ 2.21M
Median
Core Assets Benchmark AnalysisMarket
The chart above depicts the distribution of Core Assets for companies in the Total Stock Market. The average Core Assets of the companies is $ 799.74M with a standard deviation of $ 1.05B.
The following table provides additional summary stats:
Core Assets in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | $ 0 |
| max | $ 4.38B |
| average | $ 799.74M |
| median | $ 287.51M |
| std | $ 1.05B |